O.C.G.A.
O.C.G.A.

O.C.G.A. § 16-13-27.1 (2019)

Exempt anabolic steroids

✓ O.C.G.A. — 2019 edition (Public.Resource.Org Release 73)
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases: SyfertCases citing this section GA-LEGlegis.ga.gov (official) JustiaJustia CornellLII Search CasesGoogle Scholar

The following anabolic steroid containing compounds, mixtures, or preparations have been exempted as Schedule III Controlled Substances by the United States Drug Enforcement Administration, as listed in 21 C.F.R. 1308.34, and are therefore exempted from paragraph (6) of Code Section 16-13-27: TABLE OF EXEMPT ANABOLIC STEROID PRODUCTS Trade Name Androgen LA Company Forest Pharmaceuticals St. Louis, MO Andro-Estro 90-4 Rugby Labs Rockville Centre, NY depANDROGYN Forest Pharmaceuticals St. Louis, MO Quality Research Pharm Carmel, IN depTESTROGEN Maroca Pharm Phoenix, AZ Duomone Winitec Pharm Pacific, MO W. E. Hauck Alpharetta, GA Premedics Labs Gardena, CA Estratest Solvay Pharmaceuticals Marietta, GA Estratest HS Solvay Pharmaceuticals Marietta, GA Pan American Labs Covington, LA Premarin 1.25mg with Methyltestosterone Ayerst Labs, Inc. New York, NY Premarin 0.625mg with Methyltestosterone Ayerst Labs, Inc. New York, NY TEST-ESTRO Cypionates Rugby Labs Rockville Centre, NY Testosterone Cyp 50 Estradiol Cyp 2 I.D.E. Interstate Amityville, NY Testosterone Cypionate-Estradiol Cypionate Injection Best Generics N. Miami Beach, FL Testosterone Cypionate-Estradiol Cypionate Injection Schein Pharm Port Washington, NY Testosterone Cypionate-Estradiol Cypionate Injection Steris Labs, Inc. Phoenix, AZ Testosterone Cypionate-Estradiol Valerate Injection Schein Pharm Port Washington, NY Testosterone Enanthate-Estradiol Valerate Injection Steris Labs, Inc. Phoenix, AZ

History

Code 1981, § 16-13-27.1, enacted by Ga. L. 1993, p. 590, § 1.

Annotations

Code Commission notes. Pursuant to Code Section 28-9-5, in

1993, “St.” was substituted for “St” in two places in the “Company” column entries corresponding to the “Trade Name” column entries: “Androgen LA” and “depANDROGYN.”

Notes of Decisions
Cited in 3 cases (1 in the last 5 years), 1998–2021 · leading case: Combs v. State, 609 S.E.2d 198 (Ga. Ct. App. 2005).
Sort: Relevance Newest Treatment
Combs v. State, 609 S.E.2d 198 (Ga. Ct. App. 2005). · cites it 2× “That knowledge by the officer, combined with Combs’s inability to provide any documentation showing that he was in lawful possession of the drugs, established probable cause for his arrest.”
Am. Ass'n of Cab Companies, Inc. v. Olukoya, 505 S.E.2d 761 (Ga. Ct. App. 1998). · cites it 2× “OCGA § 16-13-27.1. 2 AACCI’s Exhibit 46 was a voluminous document with numerous exhibits from the Composite State Board of Medical Examiners’ proceeding against Dr.”
Kenneth Jerome Roundtree v. State (Ga. Ct. App. 2021). · cites it 2× “…§ 16-13-26 (listing Schedule II controlled substances); OCGA § 16-13-27 (listing Schedule III controlled substances); OCGA § 16-13-27.1 (listing specific exemptions from Schedule III); OCGA § 16-13-28 (listing Schedule IV controlled substances); OCGA § 16-13-29 (listing…”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.